CY9D Relative Valuation - Microbot Medical Inc

Dashboard Market News Investing Ideas Pricing

Watchlist Manager

Watchlist

Price: 1.83 EUR 0.27%

Market Cap: €44.8m

M	Microbot Medical Inc SWB:CY9D	US
C	Charter Communications Inc SWB:CQD	US
Q	QinetiQ Group PLC F:QY6	UK
	United Spirits Ltd NSE:MCDOWELL-N	IN
A	AMN Healthcare Services Inc XMUN:HCQ	US
P	PepsiCo Inc F:PEP	US
	Aegon NV MIL:1AGN	NL
	AngloGold Ashanti Ltd F:AOD1	ZA
C	Cyient DLM Ltd NSE:CYIENTDLM	IN
	Seagate Technology Holdings PLC LSE:0AD3	SG
A	Akwel SA LSE:0F8V	FR

Multiples-Based Value

There is not enough data to reliably calculate the multiples-based value of CY9D.

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is relative valuation?

How is Multiples-Based Value calculated?

CY9D Multiples-Based Value

Bear Case

Base Case

Bull Case

Valuation Multiples

View Details

Multiples Across Competitors

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.